Company Overview and News

 
NZ shares fall as Meridian faces declining hydro storage

2018-10-16 nzherald.co.nz
New Zealand shares fell for a second day with Meridian Energy lower as the power company confronts dry conditions, and exporters Comvita and Fisher & Paykel Healthcare faced a stronger kiwi dollar.
RHCGF SPKKY EBOSY NZTCY SPK NZTCF RYM EBO SKT GNE AOTUF EBOSF SYKWF PPSHY RYHTY VTHPF SKKTY GNE MEZ GEL EBO

 
Restaurant Brands leads NZ shares lower

2018-10-09 nzherald.co.nz
New Zealand shares fell for a seventh day. Rising US bond yields kept a lid on equity markets across Asia, weighing on growth-orientated stocks such as A2 Milk Co and Pushpay Holdings.
AIR FCREY ZNRGF NZTCF RYM ACKDF ANZFY AUKNY AIZ SKT ZNZ SYKWF PPSHY SKKTY SML AIA FBU RHCGF SPKKY NZTCY SPK ZEL FRCEF AIA FBU ANZLY RYHTY ANZFF MEZ

 
NZ shares slip on rising costs, dwindling business confidence

2018-10-02 nzherald.co.nz
New Zealand shares slipped as the weakest business confidence in nine years and fears over future profitability weighed on stocks linked to the local economic cycle.
AIA FBU RHCGF AIR FCREY SPKKY NZTCY SPK NZTCF RYM ACKDF FRCEF ANZFY AUKNY AIZ SKT SYKWF AIA PPSHY FBU ANZLY RYHTY SKKTY ANZFF

 
NZ shares inch higher as investors eye upcoming AGMs

2018-09-25 nzherald.co.nz
New Zealand shares edged higher as investors wait for the upcoming round of annual meetings for a clearer steer on company outlooks.
CEN AIR FCREY NZTCF ACKDF ANZFY AUKNY AIZ COENF SKT SYKWF CEN SKKTY AIA FBU SPKKY NZTCY SPK FRCEF COENY AIA FBU ANZLY OHE ANZFF MEZ

 
NZ shares edge higher, boosted by tourism data

2018-09-21 nzherald.co.nz
New Zealand shares edged higher as strong tourism data boosted prospects for airports and attraction operators. A2 Milk rose for a third day ahead of the reweighting of FTSE indices that it will have a larger presence in.
SKT FBU SYKWF FBU FCREY SKKTY FRCEF

1
Vodafone NZ float on the cards for 2019 - FT report

2018-09-17 nzherald.co.nz
Vodafone Group's incoming chief executive Nick Read says a float of the New Zealand unit is on the cards next year.
SKT SYKWF VOD VOD VODPF NZTCY SPKKY SKKTY SPK NZTCF

 
NZ shares slip back, Mercury NZ drops

2018-09-12 nzherald.co.nz
New Zealand shares dropped back, led lower by Mercury NZ and SkyCity Entertainment Group, as yesterday's gains weren't repeated.
SKT SYKWF SKC PPSHY ANZLY AIR SKKTY ANZFF ANZFY AIZ

 
NZ shares fall as investors cash in August gains; Tourism Holdings, A2 drop

2018-09-07 nzherald.co.nz
New Zealand shares fell for a third session, taking their weekly decline to 2.3 per cent, as investors cashed in some of August's gains in what was a strong month for the local market. Tourism Holdings and a2 Milk Co declined.
WYN AIR FCREY NZTCF RYM ACKDF ANZFY AUKNY AIZ KMD SKT SYKWF SKKTY KMD SML KTHDY AIA FBU RHCGF SPKKY NZTCY SPK FRCEF AIA FBU THL ANZLY RYHTY OHE ANZFF MEZ

 
Shares slump on fears of emerging market meltdown

2018-09-06 nzherald.co.nz
New Zealand's NZX-50 has been caught in a global stock market slump fueled by fears about emerging economies such as Argentina and Turkey.
SKT TME TRMEF SYKWF ANZLY AIR TME SKKTY ANZFF TDMEY ANZFY AIZ

 
NZ shares fall; A2 Milk, Sky TV drop

2018-09-05 nzherald.co.nz
New Zealand shares fell, led lower by Sky Network Television on continued earnings worries and Fisher & Paykel Healthcare, while Chorus and Arvida Group gained.
SKT MQBKY AIA SYKWF AIA SKKTY MCQEF ACKDF MQG AUKNY

 
NZ shares gain, led by Sky TV

2018-09-04 nzherald.co.nz
New Zealand shares rose as investors weigh up the prospect of a potential rate cut, spurring demand for stocks with high dividends, in a world economy that remains relatively robust. Sky Network Television, Spark New Zealand and Chorus gained.
KTHDY CEN PGC SPKKY NZTCY SPK NZTCF COENY KMD COENF SKT SYKWF CEN SKKTY KMD

 
NZ shares fall, led lower by Sky TV

2018-08-31 nzherald.co.nz
New Zealand shares dipped, led lower by Sky Network Television and Tourism Holdings, but gained over 4 per cent in the month after a busy earnings season.
TME TRMEF AIR FCREY RYM WHGPF ANZFY AIZ FTRRF CGF WHS SKT SYKWF WHOSY TME SKKTY SML FBU RHCGF THO FRCEF FBU THL ANZLY RYHTY ANZFF TDMEY

 
NZ shares drop as Sky TV, NZX fall

2018-08-30 nzherald.co.nz
New Zealand shares dropped from yesterday's record, led lower by Sky Network Television and NZX. Vector and Chorus gained.
SKT SYKWF VIL THL SKKTY THO FTRRF

 
NZ shares surge to record as market reopens

2018-08-29 nzherald.co.nz
New Zealand shares surged to a record as the market reopened after yesterday's platform failure. Synlait Milk and A2 Milk Co led the gains.
CEN FBU WBC FCREY ZNRGF WEBNF WBK FRCEF ZEL COENY COENF SKT ZNZ GNE SYKWF WBC FBU CEN SNZ SKKTY GNE GEL SML

 
Synlait Milk leads gains before trading suspended

2018-08-28 nzherald.co.nz
New Zealand shares barely traded today as the system was down for most of the day due to operational issues.
AIR THO ANZFY AIZ SKT SYKWF THL ANZLY SKKTY SKLUY SKL ANZFF SML

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 00B0C5VF4